Upexi, Inc.

  • Health Care
  • Medicinal Chemicals and Botanical Products
  • www.upexi.com
  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $223.72K
  • PE -0
  • Debt $762.50K
  • Cash $1.79M
  • EV -$804.17K
  • FCF -$759.34K

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$23.93M
EBIT-$23.28M
ROE-476%
ROA-125%
FCF-$759.34K
Equity$5.03M
Growth Stability1
PE-0.01
PEG0.08
PB0.04
P/FCF-0.29
P/S0.07
Price/Cash8
Debt/Equity0.15
Debt/FCF-1
Net Margins-37%
Gross Margins234%
Op. Margins-774%
Earnings CAGR-0%
Sales Growth YoY-84%
Sales Growth QoQ-113%
Sales CAGR-8%
FCF CAGR-0%
Equity CAGR44%
Earnings Stability-0.84
Earnings Growth YoY20%
Earnings Growth QoQ-90%
Earnings CAGR 5Y-0%
Sales CAGR 5Y-8%
FCF CAGR 5Y-0%
Equity CAGR 5Y44%
Earnings CAGR 3Y-27%
Sales CAGR 3Y-27%
Equity CAGR 3Y-40%
Market Cap$223.72K
Revenue$3.01M
Assets$18.60M
Total Debt$762.50K
Cash$1.79M
Shares Outstanding52.27K
EV-804.17K
Earnings Score6%
Moat Score1%
Safety Score66%
Final Score24%
Working Capital-2.98M
Current Ratio0.69
Gross Profit$7.05M
Shares Growth 3y15%
Equity Growth QoQ-23%
Equity Growth YoY-82%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.

SEC Filings

Direct access to Upexi, Inc. (UPXI) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Upexi, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Upexi, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -0%
Stability -84%
loading chart...

Upexi, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Upexi, Inc..

= -$7.5M
012345678910TV
fcf-$759K-$758K-$756K-$755K-$753K-$752K-$750K-$748K-$747K-$745K-$744K-$7.4M
DCF-$689K-$625K-$567K-$514K-$467K-$423K-$384K-$348K-$316K-$287K-$2.9M
Value-$7.5M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years06/202006/202106/202206/202306/2024TTM
Net Margins-73%3%-5%-22%-91%-37%
ROA-7%-4%-12%-96%-125%
ROE-3%-7%-63%-363%-476%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years06/202006/202106/202206/202306/2024TTM
Debt over FCF-0.29-1.58-72.59-0.48-1
Debt over Equity0.690.020.31.090.080.15
Growth Stability-----1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years06/202006/202106/202206/202306/2024CAGR 5Y
Revenue YoY growth-225%85%81%-68%-8%
Earnings YoY growth--111%-441%733%35%-0%
Equity YoY growth-874%36%-3%-77%44%
FCF YoY growth--125%-459%-92%146%-0%